In bladder cancer and melanoma, GA restores the E-cadherin/N-cadherin ratio, reprogramming invasive mesenchymal-like cells into a relatively quiescent epithelial-like state (Wang et al., 2022b; Wang M. et al., 2023). The gene discussed is CDH2; the disease is urinary bladder carcinoma.